We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Gives Actavis Elizabeth 483 for Laboratory Deviations
FDA Gives Actavis Elizabeth 483 for Laboratory Deviations
October 4, 2010
Actavis Elizabeth has received a Form 483 after FDA inspectors observed unjustified deviations from written laboratory mechanisms.